Literature DB >> 6436046

Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.

L Lu, L M Pelus, H E Broxmeyer.   

Abstract

The relationship between the presence of Ia-like antigens on human CFU-GEMM and BFU-E, and their responsiveness to the regulatory effects of AIF and PGE have been studied using normal human bone marrow cells. In primary methylcellulose culture the addition of 10(-6)-10(-9) M PGE1 results in the enhancement of the total number of BFU-E detected, with no observed effect on the number of CFU-GEMM. Addition of acidic isoferritins to primary cultures results in an approximately 50% inhibition of both BFU-E and CFU-GEMM proliferation. Removal of Ia+ cells by cytotoxic treatment with monoclonal antihuman HLA-DR (Ia) antibody plus C' resulted in: (a) reduction of total CFU-GEMM and BFU-E by approximately 50%, (b) abrogation of the enhancing effect of PGE on BFU-E, and (c) detection of populations of CFU-GEMM and BFU-E that are no longer sensitive to inhibition by AIF. Culture of marrow cells in suspension culture at 37 degrees C for 24 h prior to methylcellulose culture resulted in the loss of detectable Ia antigen on BFU-E and CFU-GEMM, loss of their responsiveness to AIF, loss of the enhancing effect of PGE on BFU-E, and the inability to detect cycling cells. Exposure of marrow cells to PGE, however, during the suspension phase augmented the total number of BFU-E, and CFU-GEMM detected and resulted in the detection of S-phase cells, expression of Ia antigens of both BFU-E and CFU-GEMM, and restoration of the ability to detect BFU-E and CFU-GEMM sensitivity to inhibition by AIF. After suspension culture with PGE, no further enhancement of BFU-E by PGE was observed. These results indicate that the expression of Ia antigens is important in the regulation of BFU-E and CFU-GEMM proliferation and add further evidence for a role for PGE in controlling progenitor cell Ia-antigen expression, cell cycle and, as a consequence, their proliferative capacity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436046

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  19 in total

1.  HLA-class II antigens on human hematopoietic progenitors.

Authors:  F W Busch; M Langer; G Pawelec; A Ziegler; P Wernet; H J Bühring; P Meyer; C Müller
Journal:  Blut       Date:  1987-03

Review 2.  Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function.

Authors:  Louis M Pelus; Jonathan Hoggatt
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-21       Impact factor: 3.072

3.  Inhibition of DPP4/CD26 and dmPGE₂ treatment enhances engraftment of mouse bone marrow hematopoietic stem cells.

Authors:  Hal E Broxmeyer; Louis M Pelus
Journal:  Blood Cells Mol Dis       Date:  2014-03-03       Impact factor: 3.039

4.  Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells.

Authors:  Pratibha Singh; Jonathan Hoggatt; Peirong Hu; Jennifer M Speth; Seiji Fukuda; Richard M Breyer; Louis M Pelus
Journal:  Blood       Date:  2011-11-22       Impact factor: 22.113

5.  Humanized culture medium for clinical expansion of human erythroblasts.

Authors:  Giovanni Migliaccio; Massimo Sanchez; Francesca Masiello; Valentina Tirelli; Lilian Varricchio; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Cell Transplant       Date:  2010-01-06       Impact factor: 4.064

6.  Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j.

Authors:  Arkadi Beloiartsev; Maria da Glória Rodrigues-Machado; Guo Ling Zhou; Timothy C Tan; Luca Zazzeron; Robert E Tainsh; Patricio Leyton; Rosemary C Jones; Marielle Scherrer-Crosbie; Warren M Zapol
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

7.  Treatment of Ph+ chronic myeloid leukemia by gamma interferon.

Authors:  D Russo; R Fanin; E Zuffa; C Gallizia; M Grazia Michieli; D Damiani; N Testoni; V Pecile; G Visani; R Colombini
Journal:  Blut       Date:  1989-07

Review 8.  Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking.

Authors:  J Hoggatt; L M Pelus
Journal:  Leukemia       Date:  2010-09-30       Impact factor: 11.528

9.  Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation.

Authors:  Jonathan Hoggatt; Pratibha Singh; Janardhan Sampath; Louis M Pelus
Journal:  Blood       Date:  2009-03-26       Impact factor: 22.113

10.  Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor.

Authors:  V C Broudy; K Kaushansky; G M Segal; J M Harlan; J W Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.